Citation: Sb. Patten et al., CASE-CONTROL STUDIES OF CARDIOVASCULAR MEDICATIONS AS RISK-FACTORS FOR CLINICALLY DIAGNOSED DEPRESSIVE-DISORDERS IN A HOSPITALIZED POPULATION, Canadian journal of psychiatry, 41(7), 1996, pp. 469-476
Citation: Sb. Patten et al., DEPRESSIVE SYMPTOMS ATTRIBUTABLE TO MEDICATION EXPOSURE IN A MEDICAL INPATIENT POPULATION, Canadian journal of psychiatry, 41(10), 1996, pp. 651-654
Citation: Sb. Patten et al., SELF-REPORTED DEPRESSIVE SYMPTOMS FOLLOWING TREATMENT WITH CORTICOSTEROIDS AND SEDATIVE-HYPNOTICS, International journal of psychiatry in medicine, 26(1), 1996, pp. 15-24
Citation: Sb. Patten et al., A CASE-CONTROL STUDY OF CORTICOSTEROID EXPOSURE AS A RISK FACTOR FOR CLINICALLY-DIAGNOSED DEPRESSIVE-DISORDERS IN A HOSPITALIZED POPULATION, Canadian journal of psychiatry, 40(7), 1995, pp. 396-400
Citation: Sb. Patten et al., SELF-REPORTED DEPRESSIVE SYMPTOMS IN ASSOCIATION WITH MEDICATION EXPOSURES AMONG MEDICAL INPATIENTS - A CROSS-SECTIONAL STUDY, Canadian journal of psychiatry, 40(5), 1995, pp. 264-269
Citation: Sb. Patten et al., STATISTICAL HETEROGENEITY AND CENTER EFFECTS IN CLINICAL-TRIALS OF ALPRAZOLAM, Canadian journal of psychiatry, 39(5), 1994, pp. 316-317